BioSyent, Inc. (RX.V)
17.79
-0.21
(-1.17%)
CAD |
TSXV |
Nov 13, 16:00
BioSyent Price : 17.79 for Nov. 13, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2026 | 17.81 | 17.81 | 17.70 | 17.79 | 2492.00 |
| Nov 12, 2026 | 18.19 | 18.19 | 18.00 | 18.00 | 2586.00 |
| Nov 11, 2026 | 17.87 | 18.10 | 17.87 | 18.10 | 4832.00 |
| Nov 10, 2026 | 17.91 | 17.97 | 17.80 | 17.90 | 3630.00 |
| Nov 09, 2026 | 17.80 | 18.25 | 17.80 | 17.90 | 9081.00 |
| Nov 06, 2026 | 17.55 | 17.70 | 17.50 | 17.70 | 6328.00 |
| Nov 05, 2026 | 17.39 | 17.75 | 17.10 | 17.34 | 12094.00 |
| Nov 04, 2026 | 16.85 | 17.29 | 16.85 | 17.15 | 7099.00 |
| Nov 03, 2026 | 17.05 | 17.10 | 16.85 | 16.85 | 14543.00 |
| Nov 02, 2026 | 17.29 | 17.29 | 17.05 | 17.05 | 5664.00 |
| Oct 30, 2026 | 16.90 | 17.17 | 16.90 | 17.09 | 5144.00 |
| Oct 29, 2026 | 16.81 | 16.90 | 16.80 | 16.83 | 6780.00 |
| Oct 28, 2026 | 16.80 | 17.40 | 16.80 | 17.00 | 6970.00 |
| Oct 27, 2026 | 16.70 | 16.70 | 16.69 | 16.69 | 644.00 |
| Oct 26, 2026 | 16.92 | 16.92 | 16.61 | 16.61 | 40057.00 |
| Oct 23, 2026 | 16.95 | 16.95 | 16.95 | 16.95 | 4.000 |
| Oct 22, 2026 | 17.07 | 17.07 | 16.25 | 16.95 | 11018.00 |
| Oct 21, 2026 | 17.07 | 17.07 | 17.07 | 17.07 | 350.00 |
| Oct 20, 2026 | 16.79 | 16.96 | 16.79 | 16.96 | 4479.00 |
| Oct 19, 2026 | 16.68 | 16.79 | 16.50 | 16.79 | 1725.00 |
| Oct 16, 2026 | 16.10 | 16.74 | 16.10 | 16.73 | 2348.00 |
| Oct 15, 2026 | 15.51 | 16.02 | 15.51 | 16.02 | 4260.00 |
| Oct 14, 2026 | 15.97 | 15.97 | 15.45 | 15.89 | 9597.00 |
| Oct 13, 2026 | 17.00 | 17.00 | 14.75 | 15.97 | 27732.00 |
| Oct 09, 2026 | 16.92 | 17.15 | 16.70 | 17.15 | 2466.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| HLS Therapeutics, Inc. | 3.71 |
| Bausch Health Cos., Inc. | 11.91 |
| Cipher Pharmaceuticals, Inc. | 14.17 |
| Revive Therapeutics Ltd. | 0.015 |
| Knight Therapeutics, Inc. | 12.06 |
Price Related Metrics
| PE Ratio | 20.75 |
| PS Ratio | 3.674 |
| PEG Ratio | 1.046 |
| Price to Book Value | 4.401 |
| Price to Free Cash Flow | 17.59 |
| Earnings Yield | 4.82% |
| Market Cap | 201.74M |
| PEGY Ratio | 0.9861 |
| Operating PE Ratio | 15.85 |
| Normalized PE Ratio | 20.75 |